Cetrorelix Acetate for Injection 0.25 mg Recall
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Cetrorelix Acetate for Injection 0.25 mg recalled?
Defective Delivery System: Missing or duplicated needles within the injection kit
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Which lot codes, UPCs or models are affected?
Lot Q4E0112A, Exp.: 30 Apr 2027
- Agency record number
- D-0340-2026
- Product
- Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- Recalling firm
- Meitheal Pharmaceuticals, Inc
- Quantity
- 16,477 kits
- Distribution
- U.S. Nationwide
- Recall started
- February 9, 2026
- Report date
- February 18, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)